d-alpha tocopherol has been researched along with oxycodone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Holyoak, AL; Prematuranga, S; Senthuran, S; Trout, MJ; White, RP | 1 |
| Edwards, SR; El-Tamimy, M; Gaetano, G; Gavin, P; Smith, MT; Wyse, BD | 1 |
| Brooker, C; Gavin, PD; Smith, A; Tremper, L; Williams, G | 1 |
| Gavin, PD; Schlagheck, T; Shakib, S; Simon, LS; Smith, AJ | 1 |
2 review(s) available for d-alpha tocopherol and oxycodone
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for d-alpha tocopherol and oxycodone
| Article | Year |
|---|---|
Transdermal oxycodone patch for the treatment of postherpetic neuralgia: a randomized, double-blind, controlled trial.
Topics: Adult; alpha-Tocopherol; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Humans; Male; Middle Aged; Neuralgia, Postherpetic; Outcome Assessment, Health Care; Oxycodone; Paresthesia; Transdermal Patch | 2017 |
Pharmacokinetics, safety and tolerability of a novel tocopheryl phosphate mixture/oxycodone transdermal patch system: a Phase I study.
Topics: Adult; alpha-Tocopherol; Analgesics, Opioid; Drug Combinations; Female; Healthy Volunteers; Humans; Male; Oxycodone; Transdermal Patch | 2017 |
2 other study(ies) available for d-alpha tocopherol and oxycodone
| Article | Year |
|---|---|
Toxic leukoencephalopathy in the intensive care unit.
Topics: Adult; Amphetamines; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Ascorbic Acid; Brain; Clonazepam; Diagnosis, Differential; Dibenzothiazepines; Fatal Outcome; Humans; Intensive Care Units; Leukoencephalopathies; Magnetic Resonance Imaging; Male; Mianserin; Mirtazapine; Oxycodone; Quadriplegia; Quetiapine Fumarate; Solvents; Tomography, X-Ray Computed; Ubiquinone; Vitamin E; Young Adult | 2014 |
Topical application of a novel oxycodone gel formulation (tocopheryl phosphate mixture) in a rat model of peripheral inflammatory pain produces localized pain relief without significant systemic exposure.
Topics: alpha-Tocopherol; Analgesics; Analgesics, Opioid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Gels; Inflammation; Male; Oxycodone; Pain; Pain Management; Pain Measurement; Rats; Rats, Sprague-Dawley | 2015 |